AU4850801A - Assay for acetylcholinesterase inhibitors - Google Patents

Assay for acetylcholinesterase inhibitors

Info

Publication number
AU4850801A
AU4850801A AU4850801A AU4850801A AU4850801A AU 4850801 A AU4850801 A AU 4850801A AU 4850801 A AU4850801 A AU 4850801A AU 4850801 A AU4850801 A AU 4850801A AU 4850801 A AU4850801 A AU 4850801A
Authority
AU
Australia
Prior art keywords
assay
acetylcholinesterase inhibitors
acetylcholinesterase
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU4850801A
Inventor
Eberhard Heribert Buhl
Alison Ann Robson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of AU4850801A publication Critical patent/AU4850801A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • C12Q1/46—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase involving cholinesterase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU4850801A 2000-05-02 2001-04-03 Assay for acetylcholinesterase inhibitors Pending AU4850801A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0010565A GB0010565D0 (en) 2000-05-02 2000-05-02 Assay for acetylcholinesterase inhibitors
PCT/GB2001/001519 WO2001084141A1 (en) 2000-05-02 2001-04-03 Assay for acetylcholinesterase inhibitors

Publications (1)

Publication Number Publication Date
AU4850801A true AU4850801A (en) 2001-11-12

Family

ID=9890805

Family Applications (1)

Application Number Title Priority Date Filing Date
AU4850801A Pending AU4850801A (en) 2000-05-02 2001-04-03 Assay for acetylcholinesterase inhibitors

Country Status (3)

Country Link
AU (1) AU4850801A (en)
GB (1) GB0010565D0 (en)
WO (1) WO2001084141A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3383482B1 (en) 2015-11-24 2023-01-04 Massachusetts Institute of Technology Systems for preventing, mitigating, and/or treating dementia
US10960225B2 (en) 2017-10-10 2021-03-30 Massachusetts Institute Of Technology Systems and methods for preventing, mitigating, and/or treating dementia via visual stimulation that binds higher order brain regions, reduces neurodegeneration and neuroinflammation, and improves cognitive function
WO2019074637A1 (en) 2017-10-10 2019-04-18 Massachusetts Institute Of Technology Systems and methods for preventing, mitigating, and/or treating dementia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506097A (en) * 1990-08-24 1996-04-09 President And Fellows Of Harvard College Method for inhibiting β-protein enzymatic activity
US6221670B1 (en) * 1997-03-21 2001-04-24 Scios Inc. Methods to identify β-amyloid reducing agents

Also Published As

Publication number Publication date
WO2001084141A1 (en) 2001-11-08
GB0010565D0 (en) 2000-06-21

Similar Documents

Publication Publication Date Title
HK1061030A1 (en) Rho-kinase inhibitors
HK1061029A1 (en) Rho-kinase inhibitors
GB9912961D0 (en) Metalloprotease inhibitors
IL145085A0 (en) Dihetero-substituted metalloprotease inhibitors
AU8414701A (en) Assay for soluble fibrin
GB0030284D0 (en) Enzyme inhibitors
GB0003069D0 (en) Improved assay
GB0012860D0 (en) Assay
AU4850801A (en) Assay for acetylcholinesterase inhibitors
GB0008784D0 (en) Assay
GB0101847D0 (en) Assay
GB0005894D0 (en) Assay
GB0010960D0 (en) Assay
GB0002543D0 (en) Assay method
GB0025804D0 (en) Assay
GB0001703D0 (en) Assay
AU2001248508A1 (en) Assay for acetylcholinesterase inhibitors
GB0003898D0 (en) Assay
GB0013561D0 (en) Assay
GB0019242D0 (en) Assay
GB0023239D0 (en) Assay
GB0024299D0 (en) Assay method
GB0029001D0 (en) Assay
GB0021461D0 (en) Assay method
GB0029733D0 (en) Inhibitors